Luckwel Pharmaceuticals Inc. — Net Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/27c93599-56d2-4e30-afe1-4031ad064ca9/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2020 | $-436.0k | 2020-04-01 – 2021-03-31 | evidence 0001493152-21-022312 |
| FY 2019 | $-536.4k | 2019-04-01 – 2020-03-31 | evidence 0001493152-21-014053 |
| FY 2018 | $-622.5k | 2018-04-01 – 2019-03-31 | evidence 0001493152-19-010056 |
| FY 2017 | $-537.1k | 2017-04-01 – 2018-03-31 | evidence 0001493152-18-009999 |
| FY 2016 | $-510.7k | 2016-04-01 – 2017-03-31 | evidence 0001185185-17-001459 |
| FY 2015 | $-420.7k | 2015-03-01 – 2016-02-29 | evidence 0001520138-16-000886 |
| FY 2014 | $-264.2k | 2014-03-01 – 2015-02-28 | evidence 0001520138-15-000267 |
| FY 2013 | $-224.6k | 2013-03-01 – 2014-02-28 | evidence 0001520138-15-000267 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).